AACR logo

More articles from Priority Briefs

Demographic Factors Associated with Toxicity in Patients Treated with Anti–Programmed Cell Death-1 Therapy
Kaustav P. Shah, Haocan Song, Fei Ye, Javid J. Moslehi, Justin M. Balko, Joe-Elie Salem, Douglas B. Johnson

Cancer Immunology Research Jul 2020, 8 (7) 851-855; DOI: 10.1158/2326-6066.CIR-19-0986
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer
Marie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, Thomas Holcomb, Kobe C. Yuen, Edward E. Kadel, Sanjeev Mariathasan, Daniel L. Halligan, Adrian R. Carr, Max Bylesjo, Paul R. McAdam, Sarah Lynagh, Koen M. Marien, Mark Kockx, Yannick Waumans, Shih-Min A. Huang, Mark R. Lackner, Zineb Mounir

Cancer Immunology Research Jul 2020, 8 (7) 844-850; DOI: 10.1158/2326-6066.CIR-19-0568
Early-Life Microbiota Exposure Restricts Myeloid-Derived Suppressor Cell–Driven Colonic Tumorigenesis
Akihito Harusato, Emilie Viennois, Lucie Etienne-Mesmin, Shingo Matsuyama, Hirohito Abo, Satoru Osuka, Nicholas W. Lukacs, Yuji Naito, Yoshito Itoh, Jian-Dong Li, Didier Merlin, Andrew T. Gewirtz, Timothy L. Denning

Cancer Immunology Research Apr 2019, 7 (4) 544-551; DOI: 10.1158/2326-6066.CIR-18-0444
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo, André E. Simões, Francisco Caiado, Paola Tieppo, Daniel V. Correia, Tânia Carvalho, Maria Gomes da Silva, Julie Déchanet-Merville, Ton N. Schumacher, Immo Prinz, Haakan Norell, Sarina Ravens, David Vermijlen, Bruno Silva-Santos

Cancer Immunology Research Apr 2019, 7 (4) 552-558; DOI: 10.1158/2326-6066.CIR-18-0647
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8⁺ T-cell Responses, Impacting Tumor Challenge
Elizabeth K. Duperret, Alfredo Perales-Puchalt, Regina Stoltz, Hiranjith G.H., Nitin Mandloi, James Barlow, Amitabha Chaudhuri, Niranjan Y. Sardesai, David B. Weiner

Cancer Immunology Research Feb 2019, 7 (2) 174-182; DOI: 10.1158/2326-6066.CIR-18-0283
Antagonism of IAPs Enhances CAR T-cell Efficacy
Jessica Michie, Paul A. Beavis, Andrew J. Freeman, Stephin J. Vervoort, Kelly M. Ramsbottom, Vignesh Narasimhan, Emily J. Lelliott, Najoua Lalaoui, Robert G. Ramsay, Ricky W. Johnstone, John Silke, Phillip K. Darcy, Ilia Voskoboinik, Conor J. Kearney, Jane Oliaro

Cancer Immunology Research Feb 2019, 7 (2) 183-192; DOI: 10.1158/2326-6066.CIR-18-0428
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jérôme Moreaux, Alboukadel Kassambara, Dirk Hose, Roy Heusschen, Helena Eriksson, Karin Vanderkerken, Els Van Valckenborgh

Cancer Immunology Research Oct 2017, 5 (10) 839-846; DOI: 10.1158/2326-6066.CIR-17-0192
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8⁺ T Cells
Jan Willem Kleinovink, Marieke F. Fransen, Clemens W. Löwik, Ferry Ossendorp

Cancer Immunology Research Oct 2017, 5 (10) 832-838; DOI: 10.1158/2326-6066.CIR-17-0055
Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab
Amanda Shreders, Richard Joseph, Chengwei Peng, Fei Ye, Shilin Zhao, Igor Puzanov, Jeffrey A. Sosman, Douglas B. Johnson

Cancer Immunology Research Jul 2016, 4 (7) 569-573; DOI: 10.1158/2326-6066.CIR-15-0281
Molecular Drivers of the Non–T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Randy F. Sweis, Stefani Spranger, Riyue Bao, Gladell P. Paner, Walter M. Stadler, Gary Steinberg, Thomas F. Gajewski

Cancer Immunology Research Jul 2016, 4 (7) 563-568; DOI: 10.1158/2326-6066.CIR-15-0274

Main menu

User menu

Search

More articles from Priority Briefs

Pages

Articles

Info for

About Cancer Immunology Research